Skip to main content
Fig. 4 | BMC Medicine

Fig. 4

From: A urinary assay for mutation and methylation biomarkers in the diagnosis and recurrence prediction of non-muscle invasive bladder cancer patients

Fig. 4

A proposed model to incorporate OncoUrine in clinical practice. A The potential application of OncoUrine in bladder cancer diagnosis. B The potential application of OncoUrine in recurrence diagnosis and monitoring. In both clinical settings, patients with negative test results have low risk of developing bladder cancer or recurrence and cystoscopy could be avoided. While patients with positive test results should undergo confirmatory cystoscopy

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us